1. |
Horvath KA, Parker MA, Frederiksen JW, et al. Postoperativetroponin I values: insult or injury ? Clin Cardiol, 2000, 23 (10):731-733.
|
2. |
Mair J, Larue C, Mair P, et al. Use of cardiac troponin I to diagnoseperioperative myocardial infarction in coronary artery bypass grafting.Clin Chem, 1994, 40 (11 Pt 1):2066-2070.
|
3. |
Etievent JP, Chocron S, Toubin G, et al. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg, 1995, 59 (5):1192-1194.
|
4. |
Vermes E, Mesguich M, Houel R, et al. Cardiac troponin I release after open heart surgery: a marker of myocardial protection. Ann Thorac Surg, 2000, 70 (6):2087-2090.
|
5. |
肖蒼松, 高長青, 朱朗標, 等. 冠狀動脈旁路移植術圍術期心肌肌鈣蛋白I動態變化. 中華胸心血管外科雜志, 2000, 16 (4):32-34.
|
6. |
Noora J, Ricci C, Hastings D, et al. Determination of troponin I release after CABG surgery. J Card Surg, 2005, 20 (2):129-135.
|
7. |
Kilger E, Pichler B, Weis F, et al. Markers of myocardial ischemia after minimally invasive and conventional coronary operation. Ann Thorac Sury, 2000, 70 (6):2023-2028.
|
8. |
Birdi I, Caputo M, Hutter JA, et al. Troponin I release during minimally invasive coronary artery surgery. J Thorac Cardiovasc Surg, 1997, 114 (3):509-510.
|
9. |
周峰, 高長青, 李伯君. 非體外循環與常規冠狀動脈旁路移植術后心肌酶的動態變化. 中國胸心血管外科臨床雜志, 2004, 11 (4):256-258.
|
10. |
Fellahi JL, Léger P, Philippe E, et al. Pericardial cardiac troponin I release after coronary artery bypass grafting. Anesth Analg, 1999, 89 (4):829-834.
|
11. |
De Paulis R, Colagrande L, Seddio F, et al. Levels of troponin I and cardiac enzymes after reinfusion of shed blood in coronary operations. Ann Thorac Surg, 1998, 65 (6):1617-1620.
|
12. |
Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. J ThoracCardiovasc Surg, 2012, 143 (1):4-34.
|
13. |
Eigel P, van Ingen G, Wagenpfeil S. Predictive value of perioperativecardiac troponin I for adverse outcome in coronary artery bypasssurgery. Eur J Cardiothorac Surg, 2001, 20 (3):544-549.
|
14. |
Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA, 2005, 294 (19):2446-2454.
|